Vitamin D therapy in uremic osteodystrophy: Theoretical and practical considerations

Reiss E. , Canterbury J.M. , Kanter A. : Circulating parathyroid hormone concentrations in chronic renal insufficiency. Arch. Int. Med. 124: 417–421, 1969.

O'Riordan J.L.H. , Page J. , Kerr D.N.S. : Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Quart. J. Med. 39: 359–376, 1970.

Stanbury S.W. , Lumb G.A. , and Nicholson W.F. : Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1: 793–798, 1960.

Kaye M. , Chatterjee G. , Cohen G.F. : Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis. Ann. Int. Med. 73: 225–233, 1970.

Popovtzer M.M. , Pinggera W.F. , and Robinette J.B. : Secondary hyperparathyroidism. Conservative management in patients with renal insufficiency. J. Am. Med. Assoc. 231: 960–962, 1975.

Stanbury S.W. , Lumb G.A. : Parathyroid function in chronic renal failure. Quart. J. Med. 35: 1–23, 1966.

Yendt E.R. , Connor T.B. , and Howard J.E. : In vitro calcification of rat cartilage in normal and pathological human sera with some observations on the pathogenesis of renal rickets. Bull Johns Hopk Hosp. 96: 1–19, 1955.

Russel J.G. , Termine J.D. , and Avioli L.V. : Abnormal bone mineral maturation in chronic uremic state. J. Clin. Invest. 52: 2848–2852, 1973.

Russel J.E. , and Avioli L.V. : Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation. J. Clin. Invest. 51: 3072–3079, 1972.

Liu S.H. , and Shu H.I. : Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effect of dihydrotachysterol (A.T. 10) and iron. Medicine 22: 103–161, 1943.

Dent C.E. , Harper C.M. , and Philpot G.R. : The treatment of renal-glomerular osteodystrophy. Quart. J. Med. 30: 1–31, 1961.

Stanbury S. W. : Bone disease in uremia. Am. J. Med. 44: 714–724, 1968.

Ward M.K. , Feest T.G. , Ellis H.A. : Osteomalacic dialysis osteodystrophy. Lancet 1: 841–845, 1978.

Siddiqui J. , and Kerr D.N.S. : Complications of renal failure and their response to dialysis. Brit. Med. Bull. 27: 153, 1971.

Pasen G.A. , Gray D.G. , Jaworski Z.F. : Comparison of renal osteodystrophy in patients dialyzed with deionized and non-deionized water. Trans. Am. Soc. Artif. Org. 18: 405–411, 1972.

DeLuca H. F. : 25-hydroxycholecalciferol: the probable metabolically active form of vitamin D₃. Arch. Int. Med. 124: 442–450, 1969.

Fraser D.R. , and Kodicek E. : Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature (Lond) 228: 764–766, 1970.

DeLuca H.F. , Avioli L.V. : Treatment of renal osteodystrophy with 25-hydroxycholecalciferol. Arch. Intern. Med. 126: 896–898, 1969.

Lumb G.A. , Mawer E.B. , and Stanbury S.W. : The apparent vitamin D resistance in chronic renal failure. Am. J. Med. 50: 421–441, 1971.

Haussler M.R. , Baylink D.J. , Hughes M.R. : The assay of 1-alpha-25-dihydroxyvitamin D₃: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol 5: 1513, 1976.

Brickman A.S. , Coburn J.W. , and Norman A.W. : Effect of 1,25(OH)₂vitamin D₃, the active metabolite of vitamin D in uremic man. New Engl. J. Med. 287: 891, 1972.

Tougaard L. , Sorensen E. , Brochner-Mortensen J. : Controlled trials of 1α-hydroxycholecalciferol in chronic renal failure. Lancet 1: 1044–1947, 1976.

Pierides A.M. , Ellis H.A. , Simpson W. : Variable response to long-term 1α-hydroxycholecalciferol in hemodialysis osteodystrophy. Lancet 1: 1092–1095, 1976.

Davie M.W.J. , Chalmers T.M. , Hunter J.O. : 1-alphahydroxycholecalciferol in chronic renal failure. Ann. Int. Med. 84: 281–285, 1976.

Teitelbaum S.L. , Bone J.M. , and Stein P.M. : Calcifediol in chronic renal insufficiency. J. Am. Med. Assoc. 235: 164–167, 1976.

Recker R.R. , Schoenfeld P. , Litteri J. : 24-hydroxyvitamin D in renal osteodystrophy: Results of six center trial. Preliminary report. In: Vitamin D. Biochemical, chemical and clinical aspects related to calcium metabolism. Eds. Norman A.W. W. de Gruyter Berlin and New York, 1977, pp. 649–655.

Bordier P. , Zingraff J. , Gueris J. : The effect of 1α(OH)₂D₃ and 1α,25(OH)₂D₃ on the bone in patients with renal osteodystrophy. Am. J. Med. 64: 101–107, 1978.

Russel R.G.G. , Kanis J.A. , Smith R. : Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man. Adv. Exp. Med. Biol. 103: 487–503. 1978.

Kanis J.A. , Russel R.G.G. , Taylor C.M. : Vitamin D's, minerals and renal bone disease. Mineral and Electrolyte Metabolism 2: 236–237, 1979.

Bordier Ph.J. , Chot S.T. , Eastwood J.B. : Lack of histological evidence of vitamin D abnormality in the bones of anephric patients. Clin. Sci. 44: 33–41, 1973.

Christiansen C. , Rodbro P. , Saving Christensen M. : Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet 2: 700–703, 1978.